Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.350
+0.010 (0.30%)
At close: May 20, 2025, 4:00 PM
3.449
+0.099 (2.96%)
After-hours: May 20, 2025, 7:33 PM EDT
Pulmonx Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Pulmonx stock ranges from a low of $7.50 to a high of $17. The average analyst price target of $12.07 forecasts a 260.30% increase in the stock price over the next year.
Price Target: $12.07 (+260.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pulmonx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +347.76% | May 1, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +168.66% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +407.46% | May 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +407.46% | Mar 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +407.46% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
98.89M
from 83.79M
Increased by 18.02%
Revenue Next Year
116.86M
from 98.89M
Increased by 18.17%
EPS This Year
-1.58
from -1.44
EPS Next Year
-1.44
from -1.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.4M | 124.2M | 186.6M | ||
| Avg | 98.9M | 116.9M | 145.0M | ||
| Low | 93.6M | 108.2M | 127.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2% | 25.6% | 59.6% | ||
| Avg | 18.0% | 18.2% | 24.1% | ||
| Low | 11.7% | 9.4% | 8.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.58 | -1.28 | -0.23 | ||
| Avg | -1.58 | -1.44 | -1.07 | ||
| Low | -1.58 | -1.55 | -1.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.